Health Catalyst Inc. (HCAT)
NASDAQ: HCAT
· Real-Time Price · USD
3.62
-0.03 (-0.82%)
At close: Jun 20, 2025, 3:59 PM
3.60
-0.41%
After-hours: Jun 20, 2025, 04:11 PM EDT
-0.82% (1D)
Bid | 3.56 |
Market Cap | 251.61M |
Revenue (ttm) | 311.27M |
Net Income (ttm) | -72.66M |
EPS (ttm) | -1.15 |
PE Ratio (ttm) | -3.14 |
Forward PE | 9.12 |
Analyst | Buy |
Ask | 4.07 |
Volume | 405,019 |
Avg. Volume (20D) | 574,809 |
Open | 3.71 |
Previous Close | 3.65 |
Day's Range | 3.60 - 3.74 |
52-Week Range | 3.49 - 9.24 |
Beta | 1.53 |
About HCAT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HCAT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HCAT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Health Catalyst Inc. is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+5.29%
Health Catalyst shares are trading higher after th...
Unlock content with
Pro Subscription
3 months ago
-11.13%
Health Catalyst shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY25 and Q1 sales guidance below estimates. Additionally, Stifel cut its price target on the stock from $10 to $5.